1 – 223 of 223
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Repairing the Parkinson Brain
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis : A Nested Case-Control Study with Matched Cases and Controls
(
- Contribution to journal › Article
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2018
-
Mark
The vermiform appendix impacts the risk of developing Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
(
- Contribution to journal › Article
- 2016
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Identification of multiple QTLs linked to neuropathology in the engrailed-1 heterozygous mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.
(
- Contribution to journal › Article
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
- 2015
-
Mark
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.
(
- Contribution to journal › Scientific review
-
Mark
Acceleration of α-synuclein aggregation by exosomes
(
- Contribution to journal › Article
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1.
(
- Contribution to journal › Article
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Is Exenatide the Next Big Thing in Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Adipocytes derived from PA6 cells reliably promote the differentiation of dopaminergic neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Review: The future of cell therapies and brain repair: Parkinson's disease leads the way.
(
- Contribution to journal › Scientific review
-
Mark
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
(
- Contribution to journal › Article
-
Mark
Alpha-synuclein transfers from neurons to oligodendrocytes.
(
- Contribution to journal › Article
-
Mark
Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
- 2013
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
A new approach to disease-modifying drug trials in Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mind the gut: secretion of alpha-synuclein by enteric neurons
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Nonsteroidal Selective Androgen Receptor Modulators and Selective Estrogen Receptor β Agonists Moderate Cognitive Deficits and Amyloid-β Levels in a Mouse Model of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.
(
- Contribution to journal › Article
-
Mark
α-Synuclein: The Long Distance Runner.
(
- Contribution to journal › Article
-
Mark
Inflammation and α-Synuclein's Prion-like Behavior in Parkinson's Disease-Is There a Link?
(
- Contribution to journal › Scientific review
-
Mark
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
-
Mark
Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells.
(
- Contribution to journal › Article
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Adsorption of α-Synuclein to Supported Lipid Bilayers: Positioning and Role of Electrostatics.
(
- Contribution to journal › Article
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
- 2012
-
Mark
Neuropathology in transplants in Parkinson's disease: Implications for disease pathogenesis and the future of cell therapy.
(
- Contribution to journal › Article
-
Mark
Can Parkinson's disease pathology be propagated from one neuron to another?
(
- Contribution to journal › Article
-
Mark
Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo.
(
- Contribution to journal › Article
-
Mark
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
-
Mark
The adult human brain harbors multipotent perivascular mesenchymal stem cells.
(
- Contribution to journal › Article
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
- 2011
-
Mark
Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Journal of Parkinson's Disease Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
-
Mark
Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article
-
Mark
The executioners sing a new song: killer caspases activate microglia
(
- Contribution to journal › Scientific review
-
Mark
Neurogenesis In The R6/2 Mouse Model Of Huntington'S Disease Is Impaired At The Level Of Neurod1
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease
(
- Contribution to journal › Article
-
Mark
Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Reduced neurogenesis in the rat hippocampus following high fructose consumption.
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Caspase signalling controls microglia activation and neurotoxicity.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
(
- Contribution to journal › Article
-
Mark
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Does A "Prion-Like" Mechanism Contribute to the Spreading of Neuropathology in Parkinson's Disease?
(
- Contribution to journal › Published meeting abstract
-
Mark
Neural grafting in Parkinson's disease: problems and possibilities
(
- Contribution to journal › Scientific review
-
Mark
Cell transplantation in Parkinson's disease: problems and perspectives.
(
- Contribution to journal › Article
-
Mark
Prion-like transmission of protein aggregates in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes
(
- Contribution to journal › Article
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
(
- Contribution to journal › Article
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Nitric Oxide Stimulates the Proliferation of Neural Stem Cells Bypassing the Epidermal Growth Factor Receptor
(
- Contribution to journal › Article
-
Mark
Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival
(
- Contribution to journal › Article
- 2009
-
Mark
Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Propagation of host disease to grafted neurons: Accumulating evidence
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Beyond the brain: widespread pathology in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
(
- Contribution to journal › Article
-
Mark
Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis.
(
- Contribution to journal › Article
-
Mark
BRAIN INJURY ACTIVATES MICROGLIA THAT INDUCE NEURAL STEM CELL PROLIFERATION AND PROMOTE DIFFERENTIATION OF NEUROSPHERE-DERIVED CELLS INTO NEURONS AND TO OLIGODENDROCYTES
(
- Contribution to journal › Published meeting abstract
-
Mark
Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries.
(
- Contribution to journal › Article
-
Mark
Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis.
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment
(
- Contribution to journal › Article
- 2008
-
Mark
Mutant huntingtin can paradoxically protect neurons from death
(
- Contribution to journal › Scientific review
-
Mark
Modet att ta ansvar
2008) p.155-166(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Future Cell- and Gene-Based Therapies for Parkinson's Disease
2008) p.145-156(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Protein-protein interactions in poly-Q disease model
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.1-1(
- Contribution to journal › Published meeting abstract
-
Mark
Emerging restorative treatments for Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.
(
- Contribution to journal › Article
-
Mark
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, MSX1, Ngn2, and Pitx3.
2008) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 28(14). p.3644-3656(
- Contribution to journal › Article
-
Mark
Research in motion: the enigma of Parkinson's disease pathology spread.
(
- Contribution to journal › Scientific review
-
Mark
Critical issues of clinical human embryonic stem cell therapy for brain repair.
(
- Contribution to journal › Article
-
Mark
Weight loss in Huntington's disease is related to the number of CAG repeats
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.17-17(
- Contribution to journal › Published meeting abstract
-
Mark
The effect of alpha-synuclein knockdown on MPP plus toxicity in models of human neurons
(
- Contribution to journal › Article
-
Mark
Weight loss in Huntington disease increases with higher CAG repeat number
(
- Contribution to journal › Article
-
Mark
Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus
(
- Contribution to journal › Article
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy
(
- Contribution to journal › Article
-
Mark
Increased thirst and drinking in Huntington's disease and the R6/2 mouse
(
- Contribution to journal › Article
-
Mark
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
(
- Contribution to journal › Article
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
Large stem cell grafts could lead to erroneous interpretations of behavioral results?
(
- Contribution to journal › Letter
-
Mark
Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Restorative cell therapy for Parkinson's disease: A quest for the perfect cell
(
- Contribution to journal › Scientific review
-
Mark
Adult neurogenesis in neurodegenerative diseases
2007) p.445-445(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Decreased VIP and VPAC(2) receptor expression in the biological clock of the R6/2 Huntington's disease mouse
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells.
(
- Contribution to journal › Article
-
Mark
Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line - Studies in vitro and after intracerebral grafting in vivo
(
- Contribution to journal › Article
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation.
(
- Contribution to journal › Article
-
Mark
Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
(
- Contribution to journal › Article
- 2006
-
Mark
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
(
- Contribution to journal › Letter
-
Mark
Working memory training decreases hippocampal neurogenesis.
(
- Contribution to journal › Article
-
Mark
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
(
- Contribution to journal › Article
-
Mark
Enriched Environment Attenuates Cell Genesis in Subventricular Zone After Focal Ischemia in Mice and Decreases Migration of Newborn Cells to the Striatum.
(
- Contribution to journal › Article
-
Mark
Transplantation in Parkinson's disease: The future looks bright.
(
- Contribution to journal › Article
-
Mark
High-fat diet impairs hippocampal neurogenesis in male rats.
(
- Contribution to journal › Article
-
Mark
Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Failure of transdifferentiation of adult hematopoietic stem cells into neurons.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain.
(
- Contribution to journal › Article
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cholinergic neuronal defect without cell loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation
(
- Contribution to journal › Article
- 2005
-
Mark
Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.
(
- Contribution to journal › Article
-
Mark
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review
-
Mark
Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
(
- Contribution to journal › Article
-
Mark
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
(
- Contribution to journal › Article
-
Mark
Stem cell-based therapy for Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Platelet-Derived Growth Factor (PDGF-BB) and Brain-Derived Neurotrophic Factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
(
- Contribution to journal › Article
-
Mark
Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
(
- Contribution to journal › Article
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
(
- Contribution to journal › Article
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway
(
- Contribution to journal › Article
-
Mark
Proteolysis of NR2B by calpain in the hippocampus of epileptic rats.
(
- Contribution to journal › Article
-
Mark
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
-
Mark
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra.
(
- Contribution to journal › Article
-
Mark
Stem cell therapy for Parkinson's disease: where do we stand?
(
- Contribution to journal › Scientific review
-
Mark
Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
(
- Contribution to journal › Article
- 2003
-
Mark
The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg
(
- Contribution to journal › Scientific review
-
Mark
Grafting dopamine neurons in Parkinson's disease: do stem cells have a role in the future?
(
- Contribution to journal › Article
-
Mark
Fria radikaler och sjuka proteiner - bovarna bakom Parkinsons sjukdom?[Free radicals and ailing proteins - the culprits behind Parkinson’s disease?]
(
- Contribution to journal › Article
-
Mark
Huntington's disease: a synaptopathy?
(
- Contribution to journal › Article
-
Mark
Ultrastructural characterization of dissociated embryonic ventral mesencephalic tissue treated with neuroprotectants.
(
- Contribution to journal › Article
-
Mark
Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents
(
- Contribution to journal › Article
-
Mark
Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression.
(
- Contribution to journal › Article
-
Mark
Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation.
(
- Contribution to journal › Article
-
Mark
Neural transplantation for the treatment of Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
(
- Contribution to journal › Letter
-
Mark
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Huntington's disease: the mystery unfolds?
(
- Contribution to journal › Scientific review
-
Mark
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
(
- Contribution to journal › Scientific review
-
Mark
Funding embryonic stem-cell research: will commerce counteract collaboration?
(
- Contribution to journal › Letter
-
Mark
Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity.
(
- Contribution to journal › Article
-
Mark
Stem cells: hype or hope?
(
- Contribution to journal › Scientific review
-
Mark
Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.
(
- Contribution to journal › Article
-
Mark
Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line.
(
- Contribution to journal › Article
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Dyskinesias following neural transplantation in Parkinson's disease.
(
- Contribution to journal › Article
- 2001
-
Mark
The neurobiology of cell transplantation in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease
(
- Contribution to journal › Article
-
Mark
Huntingtons sjukdom - ännu ett galet protein?
(
- Contribution to journal › Article
-
Mark
Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice
(
- Contribution to journal › Article
-
Mark
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length
(
- Contribution to journal › Article
-
Mark
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
(
- Contribution to journal › Article
-
Mark
Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death
(
- Contribution to journal › Article
-
Mark
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
(
- Contribution to journal › Article
-
Mark
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine
(
- Contribution to journal › Article
- 2000
-
Mark
FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons
(
- Contribution to journal › Article
-
Mark
Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor
(
- Contribution to journal › Article
-
Mark
Increased survival of embryonic nigral neurons when grafted to hypothermic rats
(
- Contribution to journal › Article
-
Mark
Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons
(
- Contribution to journal › Article
-
Mark
Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival
(
- Contribution to journal › Article
-
Mark
Caspase inhibition increases embryonic striatal graft survival
(
- Contribution to journal › Article
-
Mark
Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons
(
- Contribution to journal › Article
-
Mark
Improving the survival of grafted dopaminergic neurons: a review over current approaches
(
- Contribution to journal › Article
-
Mark
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
(
- Contribution to journal › Article
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
- 1999
-
Mark
Flunarizine improves the survival of grafted dopaminergic neurons
(
- Contribution to journal › Letter
-
Mark
Graft survival
(
- Contribution to journal › Letter
-
Mark
Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts
(
- Contribution to journal › Article
-
Mark
Grafts of Embryonic Dopamine Neurons in Rodent Models of Parkinson's Disease
1999) p.299-299(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Caspase inhibition reduces apoptosis and increases survival of nigral transplants
(
- Contribution to journal › Article
-
Mark
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
(
- Contribution to journal › Article
-
Mark
Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation
(
- Contribution to journal › Article
-
Mark
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
(
- Contribution to journal › Article
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article
- 1997
-
Mark
Tirilazad Mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro
(
- Contribution to journal › Article
-
Mark
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
- 1996
-
Mark
Fetal neocortical grafts placed in brain infarcts do not improve paw-reaching deficits in adult spontaneously hypertensive rats
(
- Contribution to journal › Article
- 1995
-
Mark
Neocortical grafts placed in the infarcted brain of adult rats: few or no efferent fibers grow from transplant to host
(
- Contribution to journal › Article
- 1994
-
Mark
Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: the influence of postlesion time and age of donor tissue
(
- Contribution to journal › Article
- 1993
-
Mark
Functional integration of cortical grafts placed in brain infarcts of rats
(
- Contribution to journal › Article
-
Mark
Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats
(
- Contribution to journal › Article
-
Mark
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture
(
- Contribution to journal › Article
-
Mark
Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts
(
- Contribution to journal › Article
-
Mark
Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism
(
- Contribution to journal › Article
- 1992
-
Mark
Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: ingrowth of afferent fibers from the host brain
(
- Contribution to journal › Article
-
Mark
Vascularization of fetal neocortical grafts implanted in brain infarcts in spontaneously hypertensive rats
(
- Contribution to journal › Article
-
Mark
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : one-year clinical and neurophysiological observations in two patients with putaminal implants
(
- Contribution to journal › Article
- 1990
-
Mark
The Importance of Graft Placement and Task Complexity for Transplant-Induced Recovery of Simple and Complex Sensorimotor Deficits in Dopamine Denervated Rats
(
- Contribution to journal › Article
-
Mark
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
(
- Contribution to journal › Article
- 1988
-
Mark
Immunological aspects of neural grafting in the mammalian central nervous system
(
- Contribution to journal › Article
-
Mark
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease : immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
(
- Contribution to journal › Article
- 1987
-
Mark
Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion
(
- Contribution to journal › Article
-
Mark
Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease
(
- Contribution to journal › Article